{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1146.1632",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2022-01-18T01:02:48.000-05:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1632",
  "version": "20220118",
  "name": "Glecaprevir Pibrentasvir Combination (RXNORM)",
  "status": "active",
  "date": "2022-01-18T01:02:48-05:00",
  "publisher": "CSTE Steward",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05022022",
        "concept": [
          {
            "code": "1940703",
            "display": "glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet"
          },
          {
            "code": "1940709",
            "display": "glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret]"
          },
          {
            "code": "2557906",
            "display": "glecaprevir 50 MG / pibrentasvir 20 MG Oral Pellet"
          },
          {
            "code": "2557910",
            "display": "glecaprevir 50 MG / pibrentasvir 20 MG Oral Pellet [Mavyret]"
          }
        ]
      }
    ]
  }
}